{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:18:38Z","timestamp":1793395118468,"version":"4.5.0"},"reference-count":29,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Cancer Institute","award":["ZIE SC000853"],"award-info":[{"award-number":["ZIE SC000853"]}]},{"name":"National Cancer Institute","award":["ZIA BC011405"],"award-info":[{"award-number":["ZIA BC011405"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background\/Objectives: Prostate cancer is the second most frequent cancer among men and the 5th leading cause of cancer death among men worldwide. Identification of urine-derived biomarkers, such as exosomal miRNAs, in liquid biopsies for prostate cancer could be very beneficial for screening and active surveillance. Methods: Urine was collected from 42 patients with biopsy-proven evidence of prostate cancer and exosomes were extracted. Transcriptomic analysis was performed on the urine-derived exosomal miRNA and compared to the urine-derived exosomal miRNA profiles from 10 normal control donors and 15 von Hippel-Lindau (VHL) syndrome patients with clear cell renal cell carcinoma (ccRCC). Results: Urine-derived exosomal miRNA profiles of prostate patients were significantly different from normal control individuals. Significantly increased expression of miR-122-5p and decreased expression of miR-125-5p and miR-16-5p were observed in the urine-derived exosomes from prostate cancer patients. Significant upregulation of miR-30a-5p and downregulation of miR-320-5p, miR-320b, and miR-320c were observed in the urine-derived exosomes from both prostate cancer patients and VHL patients with ccRCC, indicating these miRNAs could be non-specific markers of urological cancer. Increased expression of miR-10a-5p and miR-30e-5p or miR-532-5p and miR-206 correlated with the presence of either extracapsular or perineural invasion, respectively. Conclusions: This study highlights the potential for urine-derived exosomal miRNA profiles to identify the presence of prostate cancer and predict clinical features, additionally showing that miRNA signals could be non-specific markers of urologic cancer types. Further validation studies are necessary to demonstrate the utility of urine-derived exosomal miRNA profiles as biomarkers for diagnosis or prognosis in prostate cancer.<\/jats:p>","DOI":"10.3390\/genes17070802","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:29:39Z","timestamp":1784100579000},"page":"802","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating the Urinary Exosome MicroRNA Profile in Prostate Cancer"],"prefix":"10.3390","volume":"17","author":[{"given":"Beatriz","family":"Walter Rodriguez","sequence":"first","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4814-7207","authenticated-orcid":false,"given":"Christopher J.","family":"Ricketts","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baris","family":"Turkbey","sequence":"additional","affiliation":[{"name":"Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Pinto","sequence":"additional","affiliation":[{"name":"Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Merino","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Wang, L., Lu, B., He, M., Wang, Y., Wang, Z., and Du, L. (2022). Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.811044"},{"key":"ref_2","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Merriel, S.W.D., Pocock, L., Gilbert, E., Creavin, S., Walter, F.M., Spencer, A., and Hamilton, W. (2022). Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients. BMC Med., 20.","DOI":"10.1186\/s12916-021-02230-y"},{"key":"ref_4","first-page":"300","article-title":"Modern biomarkers in prostate cancer diagnosis","volume":"73","author":"Porzycki","year":"2020","journal-title":"Cent. Eur. J. Urol."},{"key":"ref_5","first-page":"81","article-title":"Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer","volume":"4","author":"Caputo","year":"2023","journal-title":"Explor. Target. Antitumor Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","article-title":"Liquid biopsy in cancer current: Status, challenges and future prospects","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.apsb.2021.01.001","article-title":"The biology, function, and applications of exosomes in cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12967-021-03215-4","article-title":"The role of Exosomal miRNAs in cancer","volume":"20","author":"Li","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/ijc.34434","article-title":"Urine biomarkers in cancer detection: A systematic review of preanalytical parameters and applied methods","volume":"152","author":"Jordaens","year":"2023","journal-title":"Int. J. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Oshi, M., Murthy, V., Takahashi, H., Huyser, M., Okano, M., Tokumaru, Y., Rashid, O.M., Matsuyama, R., Endo, I., and Takabe, K. (2021). Urine as a Source of Liquid Biopsy for Cancer. Cancers, 13.","DOI":"10.3390\/cancers13112652"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/sj.bjc.6605058","article-title":"Prostate cancer-derived urine exosomes: A novel approach to biomarkers for prostate cancer","volume":"100","author":"Nilsson","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41391-021-00456-8","article-title":"Predicting high-grade prostate cancer at initial biopsy: Clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies","volume":"25","author":"Margolis","year":"2022","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jamaoncol.2016.0097","article-title":"A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy","volume":"2","author":"McKiernan","year":"2016","journal-title":"JAMA Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"E Bryzgunova, O., Zaripov, M.M., E Skvortsova, T., A Lekchnov, E., E Grigor\u2019Eva, A., A Zaporozhchenko, I., Morozkin, E.S., I Ryabchikova, E., Yurchenko, Y.B., and E Voitsitskiy, V. (2016). Comparative Study of Extracellular Vesicles from the Urine of Healthy Individuals and Prostate Cancer Patients. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0157566"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12943-017-0726-4","article-title":"Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes","volume":"16","author":"Hessvik","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/pros.23295","article-title":"Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis","volume":"77","author":"Foj","year":"2017","journal-title":"Prostate"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.euf.2017.02.018","article-title":"Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine","volume":"4","author":"Rasmussen","year":"2018","journal-title":"Eur. Urol. Focus."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Walter-Rodriguez, B., Ricketts, C.J., Linehan, W.M., and Merino, M.J. (2024). Evaluating the Urinary Exosome microRNA Profile of von Hippel Lindau Syndrome Patients with Clear Cell Renal Cell Carcinoma. Genes, 15.","DOI":"10.3390\/genes15070905"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/nar\/gkr688","article-title":"miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades","volume":"40","author":"Friedlander","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/JU.0000000000004421","article-title":"Clinical Validation of MyProstateScore 2.0 Testing Using First-Catch, Non-Digital Rectal Examination Urine","volume":"213","author":"Tosoian","year":"2025","journal-title":"J. Urol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/JU.0000000000001020","article-title":"Expression of Small Noncoding RNAs in Urinary Exosomes Classifies Prostate Cancer into Indolent and Aggressive Disease","volume":"204","author":"Wang","year":"2020","journal-title":"J. Urol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Stella, M., Russo, G.I., Leonardi, R., Carc\u00f2, D., Gattuso, G., Falzone, L., Ferrara, C., Caponnetto, A., Battaglia, R., and Libra, M. (2024). Extracellular RNAs from Whole Urine to Distinguish Prostate Cancer from Benign Prostatic Hyperplasia. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251810079"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.csbj.2022.02.002","article-title":"Identification of key miRNAs in prostate cancer progression based on miRNA-mRNA network construction","volume":"20","author":"Santo","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7150\/jca.6394","article-title":"Comprehensive microRNA Profiling of Prostate Cancer","volume":"4","author":"Walter","year":"2013","journal-title":"J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"21290","DOI":"10.1038\/s41598-020-77774-9","article-title":"Detection of urinary miRNAs for diagnosis of clear cell renal cell carcinoma","volume":"10","author":"Cochetti","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"10402","DOI":"10.18632\/oncotarget.23781","article-title":"Serum levels of miR-320 family members are associated with clinical parameters and diagnosis in prostate cancer patients","volume":"9","author":"Lieb","year":"2018","journal-title":"Oncotarget"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41416-021-01598-1","article-title":"Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients","volume":"126","author":"Berge","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/CMAR.S272140","article-title":"Identification of Urinary Exosomal miRNAs for the Non-Invasive Diagnosis of Prostate Cancer","volume":"13","author":"Li","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1038\/s41598-021-86785-z","article-title":"Urinary exosomal microRNA profiling in intermediate-risk prostate cancer","volume":"11","author":"Kim","year":"2021","journal-title":"Sci. Rep."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/7\/802\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:21:53Z","timestamp":1784262113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/7\/802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["genes17070802"],"URL":"https:\/\/doi.org\/10.3390\/genes17070802","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]}}}